TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares have surged over 40% in a single session and over 160% in the last 30 days, despite no company-specific news. The stock has seen heavy trading volume, with over 10 million shares traded in the session, significantly higher than the 100-day average of 654 thousand shares. Last week, the company announced that Superlatus, a company it recently merged with, agreed to acquire The Urgent Company and its portfolio of brands.